Beneficial Impact of Apremilast on Palmoplantar Keratodermas

Acta Derm Venereol. 2021 Apr 26;101(4):adv00437. doi: 10.2340/00015555-3805.

Authors

Kimiko Nakajima¹, Riho Nakajima, Hiroyuki Morisaka, Hideki Nakajima, Shigetoshi Sano

Affiliation

¹ Department of Dermatology , Kochi Medical School, Kochi University, 185-1 Kohasu, Okohcho, Nankoku, Kochi 783-8505, Japan. E-mail: nakajimk@kochi-u.ac.jp.

No abstract available

Keywords: apremilast; psoriasis; palmoplantar keratodermas.

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Humans
Keratoderma, Palmoplantar*
Psoriasis* / drug therapy
Thalidomide / analogs & derivatives
Thalidomide / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast